In our study, we found that CCAT2 binds to miR-200b to suspend its inhibitory effects on IGF2BP2 expression, that resulting in elevated TK1 expression, which promoted the development of ESCC. This evidence concerns the gene TK1 and esophageal squamous cell carcinoma.